Moleculent is the Biotechnology Research company.
Moleculent has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Moleculent's investors include ARCH Venture Partners, EIR Ventures, Rubicon Healthcare Partners.
Moleculent is headquartered in Solna, Sweden.
Moleculent is the Biotechnology Research company.
Moleculent is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moleculent — Funding & Investors." VCBacked, April 30, 2026, https://www.vcbacked.co/company/moleculent. Accessed September 7, 2026.
VCBacked. (2026). Moleculent — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/moleculent
{{cite web |title=Moleculent — Funding & Investors |url=https://www.vcbacked.co/company/moleculent |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated